Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 2/2015

01.02.2015 | Original Article – Clinical Oncology

Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center

verfasst von: Yen-Lin Chen, Cheng-Yi Wang, Chin-Chia Wu, Moon-Sing Lee, Shih-Kai Hung, Wei-Chou Chen, Chih-Yao Hsu, Chia-Wen Hsu, Chih-Yuan Huang, Yu-Chieh Su, Ching-Chih Lee

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

The utility of lymph node ratio (LNR) in predicting outcomes has been reported previously. In current study, we further subgroup by LNR in subjects with lymph nodes metastasis of colorectal cancer, breast cancer, and head and neck cancer.

Methods

Cancers with pathological lymph node metastasis (pN+) at time of diagnosis between 2004 and 2012 were identified from the cancer registry database of the Dalin Tzu Chi General Hospital. The Kaplan–Meier method with log-rank test and the Cox proportional hazards model were used to compare the disease-specific survival (DSS) rates for different LNR after adjusting for possible confounding risk factors.

Results

A total of 431 cancer patients with pN+ were eligible in the current study: 149 patients with colorectal cancer; 141 patients with breast cancer; and 141 patients with head and neck cancer. High LNR was associated with poor DSS rates with the mean 24–45 months of follow-up period. In the multivariate analysis, high LNR was an independent poor prognostic factor in colorectal cancer (LNR ≥ 0.5; HR 4.10; p < 0.001), breast cancer (LNR ≥ 0.8; HR 5.75; p = 0.002), and head and neck cancer (LNR ≥ 0.4; HR 2.56; p = 0.005).

Conclusion

High LNR exerts a significant role as a negative prognostic factor when comparing the traditional American Joint Committee on Cancer (AJCC) lymph nodes classification for major cancers. Therefore, LNR could be considered as an alternative and superior to, at least partially, traditional AJCC lymph nodes classification for cancer patients.
Literatur
Zurück zum Zitat Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99(6):433–441PubMedCrossRef Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99(6):433–441PubMedCrossRef
Zurück zum Zitat Chen SL, Bilchik AJ (2006) More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 244(4):602–610PubMedCentralPubMed Chen SL, Bilchik AJ (2006) More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 244(4):602–610PubMedCentralPubMed
Zurück zum Zitat Ferris RL, Lotze MT, Leong SP, Hoon DS, Morton DL (2012) Lymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread. Clin Exp Metastasis 29(7):729–736PubMedCentralPubMedCrossRef Ferris RL, Lotze MT, Leong SP, Hoon DS, Morton DL (2012) Lymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread. Clin Exp Metastasis 29(7):729–736PubMedCentralPubMedCrossRef
Zurück zum Zitat Head SI, Stephenson DG, Williams DA (1990) Properties of enzymatically isolated skeletal fibres from mice with muscular dystrophy. J Physiol 422:351–367PubMedCentralPubMedCrossRef Head SI, Stephenson DG, Williams DA (1990) Properties of enzymatically isolated skeletal fibres from mice with muscular dystrophy. J Physiol 422:351–367PubMedCentralPubMedCrossRef
Zurück zum Zitat Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli NJ, Stulc JP, Mittelman A (1987) Metastases in small lymph nodes from colon cancer. Arch Surg 122(11):1253–1256PubMedCrossRef Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli NJ, Stulc JP, Mittelman A (1987) Metastases in small lymph nodes from colon cancer. Arch Surg 122(11):1253–1256PubMedCrossRef
Zurück zum Zitat Kang J, Hur H, Min BS, Lee KY, Kim NK (2011) Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation. J Surg Oncol 104(1):53–58PubMedCrossRef Kang J, Hur H, Min BS, Lee KY, Kim NK (2011) Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation. J Surg Oncol 104(1):53–58PubMedCrossRef
Zurück zum Zitat Kwan ML, Haque R, Lee VS, Joanie Chung WL, Avila CC, Clancy HA, Quinn VP, Kushi LH (2012) Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries. Cancer Causes Control 23(9):1587–1591PubMedCentralPubMedCrossRef Kwan ML, Haque R, Lee VS, Joanie Chung WL, Avila CC, Clancy HA, Quinn VP, Kushi LH (2012) Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries. Cancer Causes Control 23(9):1587–1591PubMedCentralPubMedCrossRef
Zurück zum Zitat Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG (2003) Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21(15):2912–2919PubMedCrossRef Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG (2003) Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21(15):2912–2919PubMedCrossRef
Zurück zum Zitat Lee SD, Kim TH, Kim DY, Baek JY, Kim SY, Chang HJ, Park SC, Park JW, Oh JH, Jung KH (2012) Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection. Eur J Surg Oncol 38(6):478–483PubMedCrossRef Lee SD, Kim TH, Kim DY, Baek JY, Kim SY, Chang HJ, Park SC, Park JW, Oh JH, Jung KH (2012) Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection. Eur J Surg Oncol 38(6):478–483PubMedCrossRef
Zurück zum Zitat Liao CT, Hsueh C, Lee LY, Lin CY, Fan KH, Wang HM, Huang SF, Chen IH, Kang CJ, Ng SH, Tsao CK, Huang YC, Yen TC (2012) Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. Oral Oncol 48(4):329–336PubMedCrossRef Liao CT, Hsueh C, Lee LY, Lin CY, Fan KH, Wang HM, Huang SF, Chen IH, Kang CJ, Ng SH, Tsao CK, Huang YC, Yen TC (2012) Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. Oral Oncol 48(4):329–336PubMedCrossRef
Zurück zum Zitat Lu YJ, Lin PC, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Liang WY, Chen WS, Lin JK, Chang SC (2013) The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients. World J Surg 37(8):1927–1933PubMedCrossRef Lu YJ, Lin PC, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Liang WY, Chen WS, Lin JK, Chang SC (2013) The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients. World J Surg 37(8):1927–1933PubMedCrossRef
Zurück zum Zitat Medani M, Kelly N, Samaha G, Duff G, Healy V, Mulcahy E, Condon E, Waldron D, Saunders J, Coffey JC (2013) An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all. Int J Colorectal Dis 28(10):1377–1384PubMedCrossRef Medani M, Kelly N, Samaha G, Duff G, Healy V, Mulcahy E, Condon E, Waldron D, Saunders J, Coffey JC (2013) An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all. Int J Colorectal Dis 28(10):1377–1384PubMedCrossRef
Zurück zum Zitat Monig SP, Baldus SE, Zirbes TK, Schroder W, Lindemann DG, Dienes HP, Holscher AH (1999) Lymph node size and metastatic infiltration in colon cancer. Ann Surg Oncol 6(6):579–581PubMedCrossRef Monig SP, Baldus SE, Zirbes TK, Schroder W, Lindemann DG, Dienes HP, Holscher AH (1999) Lymph node size and metastatic infiltration in colon cancer. Ann Surg Oncol 6(6):579–581PubMedCrossRef
Zurück zum Zitat Resch A, Langner C (2013) Lymph node staging in colorectal cancer: old controversies and recent advances. World J Gastroenterol 19(46):8515–8526PubMedCentralPubMedCrossRef Resch A, Langner C (2013) Lymph node staging in colorectal cancer: old controversies and recent advances. World J Gastroenterol 19(46):8515–8526PubMedCentralPubMedCrossRef
Zurück zum Zitat Rudra S, Spiotto MT, Witt ME, Blair EA, Stenson K, Haraf DJ (2013) Lymph node density—prognostic value in head and neck cancer. Head Neck 36(2):266–272PubMedCrossRef Rudra S, Spiotto MT, Witt ME, Blair EA, Stenson K, Haraf DJ (2013) Lymph node density—prognostic value in head and neck cancer. Head Neck 36(2):266–272PubMedCrossRef
Zurück zum Zitat Saxena N, Hartman M, Yip CH, Bhoo-Pathy N, Khin LW, Taib NA, Looi LM, Lim SE, Lee SC, Verkooijen HM (2012) Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients? PLoS One 7(9):e45809PubMedCentralPubMedCrossRef Saxena N, Hartman M, Yip CH, Bhoo-Pathy N, Khin LW, Taib NA, Looi LM, Lim SE, Lee SC, Verkooijen HM (2012) Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients? PLoS One 7(9):e45809PubMedCentralPubMedCrossRef
Zurück zum Zitat Sjo OH, Merok MA, Svindland A, Nesbakken A (2012) Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum 55(3):307–315PubMedCrossRef Sjo OH, Merok MA, Svindland A, Nesbakken A (2012) Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum 55(3):307–315PubMedCrossRef
Zurück zum Zitat Storli KE, Sondenaa K, Bukholm IR, Nesvik I, Bru T, Furnes B, Hjelmeland B, Iversen KB, Eide GE (2011) Overall survival after resection for colon cancer in a national cohort study was adversely affected by TNM stage, lymph node ratio, gender, and old age. Int J Colorectal Dis 26(10):1299–1307PubMedCentralPubMedCrossRef Storli KE, Sondenaa K, Bukholm IR, Nesvik I, Bru T, Furnes B, Hjelmeland B, Iversen KB, Eide GE (2011) Overall survival after resection for colon cancer in a national cohort study was adversely affected by TNM stage, lymph node ratio, gender, and old age. Int J Colorectal Dis 26(10):1299–1307PubMedCentralPubMedCrossRef
Zurück zum Zitat Tarantino I, Achermann P, Guller U, Ulrich A, Schmied BM, Horber D, Cerny T, Stanga Z, Warschkow R (2013) Relative survival is an adequate estimate of cancer-specific survival: baseline mortality-adjusted 10-year survival of 771 rectal cancer patients. Ann Surg Oncol 20(12):3877–3884PubMedCrossRef Tarantino I, Achermann P, Guller U, Ulrich A, Schmied BM, Horber D, Cerny T, Stanga Z, Warschkow R (2013) Relative survival is an adequate estimate of cancer-specific survival: baseline mortality-adjusted 10-year survival of 771 rectal cancer patients. Ann Surg Oncol 20(12):3877–3884PubMedCrossRef
Zurück zum Zitat Thomas M, Biswas S, Mohamed F, Chandrakumaran K, Jha M, Wilson R (2012) Dukes C colorectal cancer: is the metastatic lymph node ratio important? Int J Colorectal Dis 27(3):309–317PubMedCrossRef Thomas M, Biswas S, Mohamed F, Chandrakumaran K, Jha M, Wilson R (2012) Dukes C colorectal cancer: is the metastatic lymph node ratio important? Int J Colorectal Dis 27(3):309–317PubMedCrossRef
Zurück zum Zitat Tong LL, Gao P, Wang ZN, Song YX, Xu YY, Sun Z, Xing CZ, Wang X, Xu HM (2011) Can lymph node ratio take the place of pN categories in the UICC/AJCC TNM classification system for colorectal cancer? Ann Surg Oncol 18(9):2453–2460PubMedCrossRef Tong LL, Gao P, Wang ZN, Song YX, Xu YY, Sun Z, Xing CZ, Wang X, Xu HM (2011) Can lymph node ratio take the place of pN categories in the UICC/AJCC TNM classification system for colorectal cancer? Ann Surg Oncol 18(9):2453–2460PubMedCrossRef
Zurück zum Zitat Truong PT, Berthelet E, Lee J, Kader HA, Olivotto IA (2005) The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 103(10):2006–2014PubMedCrossRef Truong PT, Berthelet E, Lee J, Kader HA, Olivotto IA (2005) The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 103(10):2006–2014PubMedCrossRef
Zurück zum Zitat Tuna S, Dalkilic Calis M, Sakar B, Aykan F, Camlica H, Topuz E (2011) Prognostic significance of the metastatic lymph node ratio for survival in colon cancer. J BUON 16(3):478–485PubMed Tuna S, Dalkilic Calis M, Sakar B, Aykan F, Camlica H, Topuz E (2011) Prognostic significance of the metastatic lymph node ratio for survival in colon cancer. J BUON 16(3):478–485PubMed
Zurück zum Zitat Wang F, He W, Qiu H, Wang X, Guo G, Chen X, Rong Y, Zhou F, Yin C, Yuan Z, Xia L (2012) Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer. Clin Breast Cancer 12(6):404–411PubMedCrossRef Wang F, He W, Qiu H, Wang X, Guo G, Chen X, Rong Y, Zhou F, Yin C, Yuan Z, Xia L (2012) Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer. Clin Breast Cancer 12(6):404–411PubMedCrossRef
Zurück zum Zitat Wong SL (2009) Lymph node counts and survival rates after resection for colon and rectal cancer. Gastrointest Cancer Res 3(2 Suppl.):S33–S35PubMedCentralPubMed Wong SL (2009) Lymph node counts and survival rates after resection for colon and rectal cancer. Gastrointest Cancer Res 3(2 Suppl.):S33–S35PubMedCentralPubMed
Zurück zum Zitat Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 17(9):2896–2900PubMed Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 17(9):2896–2900PubMed
Zurück zum Zitat Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W Jr, Foshag LJ, Bilchik AJ (2001) Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 8(2):150–157PubMedCrossRef Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W Jr, Foshag LJ, Bilchik AJ (2001) Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 8(2):150–157PubMedCrossRef
Zurück zum Zitat Wu SG, He ZY, Li Q, Sun JY, Li FY, Lin Q, Lin HX, Guan XX (2013) Prognostic value of metastatic axillary lymph node ratio for Chinese breast cancer patients. PLoS ONE 8(4):e61410PubMedCentralPubMedCrossRef Wu SG, He ZY, Li Q, Sun JY, Li FY, Lin Q, Lin HX, Guan XX (2013) Prognostic value of metastatic axillary lymph node ratio for Chinese breast cancer patients. PLoS ONE 8(4):e61410PubMedCentralPubMedCrossRef
Metadaten
Titel
Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center
verfasst von
Yen-Lin Chen
Cheng-Yi Wang
Chin-Chia Wu
Moon-Sing Lee
Shih-Kai Hung
Wei-Chou Chen
Chih-Yao Hsu
Chia-Wen Hsu
Chih-Yuan Huang
Yu-Chieh Su
Ching-Chih Lee
Publikationsdatum
01.02.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 2/2015
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-014-1810-4

Weitere Artikel der Ausgabe 2/2015

Journal of Cancer Research and Clinical Oncology 2/2015 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.